Company page
Orientbio, Inc.
Orientbio, Inc. is a public company traded under the ticker 002630 on the Korean market. The company has a market capitalization of approximately 34.54 million USD. Orientbio focuses on biotechnology and related sectors, contributing to advancements in healthcare and life sciences.
- Ticker
- 002630:KRX
- Asset type
- Stock
- Market cap
- $34.5M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- KRX
- Currency
- KRW